Now showing items 1-14 of 14

    • Sieveking, Ivan; Thomas, Pablo; Estévez, Juan C.; Quiñones, Natalia; Cuéllar, Mauricio A.; Villena, Juan; Espinosa Bustos, Christian; Fierro, Angélica; Tapia, Ricardo A.; Maya Arango, Juan; López Muñoz, Rodrigo; Cassels Niven, Bruce; Estévez, Ramón J.; Salas, Cristian (Elsevier, 2014)
      A series of new 2-aminonaphthoquinones and related compounds were synthesized and evaluated in vitro as trypanocidal and cytotoxic agents. Some tested compounds inhibited epimastigote growth and trypomastigote viability. ...
    • Díaz Urrutia, Christian; Olea Azar, Claudio; Zapata, Gerald A.; Lapier, Michel; Mura Mardones, Francisco; Aguilera Venegas, Benjamín; Arán, Vicente J.; López Muñoz, Rodrigo; Maya Arango, Juan (2012)
      A series of fused tri- and tetracyclic indazoles and analogues compounds (NID) with potential antiparasitic effects were studied using voltamperometric and spectroscopic techniques. Nitroanion radicals generated by cyclic ...
    • Faúndez, Mario; López Muñoz, Rodrigo; Torres, Gloria; Morello Casté, Antonio; Ferreira, Jorge; Kemmerling Weis, Ulrike; Orellana Bown, Myriam; Maya Arango, Juan (AMER SOC MICROBIOLOGY, 2008)
      L-Buthionine (S,R)-sulfoximine (BSO) at a dose of 220 mg/kg of body weight/day showed an anti-Trypanosoma cruzi effect in infected mice, increasing their survival rate and decreasing the parasitemias and parasite burden ...
    • Maya Arango, Juan; Orellana, Myriam; Ferreira, Jorge; Kemmerling Weis, Ulrike; López Muñoz, Rodrigo; Morello Casté, Antonio (Society of Biology of Chile, 2010)
      There are approximately 7.8 million people in Latin America, including Chile, who suffer from Chagas disease and another 28 million who are at risk of contracting it. Chagas is caused by the flagellate protozoan Trypanosoma ...
    • Zuluaga, L.; Parra, S.; Garrido, E.; López Muñoz, Rodrigo; Maya Arango, Juan; Blair, S. (2013)
      Dehydroepiandrosterone (DHEA) inhibits glucose 6-phosphate dehydrogenase (G6PDH) of different species and may potentially decrease intracellular glutathione. Therefore, it can have and enhance anti-parasitic action against ...
    • Lapier, Michel; Zúñiga López, María C.; Aguilera Venegas, Benjamín; Adam, Rosa; Abarca, Belén; Ballesteros, Rafael; López Muñoz, Rodrigo; Maya Arango, Juan; Olea Azar, Claudio (Bentham Science Publishers B.V., 2017)
      © 2017 Bentham Science Publishers. Trypanosoma cruzi is the causative agent of Chagas disease. This parasite is vulnerable to the effects of ROS as its main defense mechanism against exogenous agents trypanothione is also ...
    • Muñoz, Orlando M.; Maya Arango, Juan; Ferreira, Jorge; Christen, Philippe; San Martín, José; López Muñoz, Rodrigo; Morello Casté, Antonio; Kemmerling Weis, Ulrike (Verlag der Zeitschrift fur Naturforschung, 2013)
      The extracts of several plants of Central Chile exhibited anti-Trypanosoma cruzi trypomastigotes activity. Most active extracts were those obtained from Podanthus ovatifolius, Berberis microphylla, Kageneckia oblonga, and ...
    • Díaz, María V.; Miranda, Mariana R.; Campos Estrada, Carolina; Reigada, Chantal; Maya Arango, Juan; Pereira, Claudio A.; López Muñoz, Rodrigo (Elsevier, 2014)
      Pentamidine is an antiprotozoal and fungicide drug used in the treatment of leishmaniasis and African trypanosomiasis. Despite its extensive use as antiparasitic drug, little evidence exists about the effect of pentamidine ...
    • Díaz, María V.; Miranda, Mariana R.; Campos Estrada, Carolina; Reigada, Chantal; Maya Arango, Juan; Pereira, Claudio A.; López Muñoz, Rodrigo (Elsevier, 2014)
      Pentamidine is an antiprotozoal and fungicide drug used in the treatment of leishmaniasis and Africantrypanosomiasis. Despite its extensive use as antiparasitic drug, little evidence exists about the effect ofpentamidine ...
    • Molina Berríos, Alfredo Enrique; Campos Estrada, Carolina; Henríquez, Natalia; Faúndez, Mario; Torres, Gloria; Castillo, Christian; Escanilla, Sebastián; Kemmerling Weis, Ulrike; Morello Casté, Antonio; López Muñoz, Rodrigo; Maya Arango, Juan (PLoS, 2013)
      Chagas’ disease, produced by Trypanosoma cruzi, affects more than 8 million people, producing approximately 10,000 deaths each year in Latin America. Migration of people from endemic regions to developed countries has ...
    • Molina Berríos, Alfredo Enrique; Campos Estrada, Carolina; Henriquez, Natalia; Faúndez, Mario; Torres, Gloria; Castillo, Christian; Escanilla, Sebastián; Kemmerling Weis, Ulrike; Morello Casté, Antonio; López Muñoz, Rodrigo; Maya Arango, Juan (Public Library of Science, 2013)
      Chagas' disease, produced by Trypanosoma cruzi, affects more than 8 million people, producing approximately 10,000 deaths each year in Latin America. Migration of people from endemic regions to developed countries has ...
    • Ramírez, Galia; Valck Calderón, Carolina Eliana; Aguilar, Lorena; Kemmerling Weis, Ulrike; López Muñoz, Rodrigo; Navarro Cabrera, Gonzalo; Morello Casté, Antonio; Ferreira, Jorge; Maya Arango, Juan; Galanti Garrone, Norbel; Ferreira, Arturo (2012)
      In Latin America, there are about 10-12 million people infected with Trypanosoma cruzi, the agent of Chagas' disease, one of the most important neglected tropical parasitism. Identification of molecular targets, specific ...
    • Campos Estrada, Carolina; Liempi, Ana; González Herrera, Fabiola; Lapier, Michel; Kemmerling Weis, Ulrike; Pesce Reyes, Bárbara; Ferreira, Jorge; López Muñoz, Rodrigo; Maya Arango, Juan (Public Library of Science, 2015)
      © 2015 Campos-Estrada et al.Trypanosoma cruzi is the causal agent of Chagas Disease that is endemic in Latin American, afflicting more than ten million people approximately. This disease has two phases, acute and chronic. ...
    • Duaso, J.; Rojo, G.; Jaña, F.; Galanti Garrone, Norbel; Cabrera, G.; Bosco, C.; López Muñoz, Rodrigo; Maya Arango, Juan; Ferreira, J.; Kemmerling Weis, Ulrike (2011)
      Chagas' disease, produced by the haemoflagellated protozoan Trypanosoma cruzi (T. cruzi), is one of the most frequent endemic diseases in Latin America. In spite that in the past few years T. cruzi congenital transmission ...